OriGene offers 50% discount on over 4,000 full-length human proteins.

Now is the best time to try OriGene's full length recombinant proteins, expressed in HEK293 cells.

  • Low Price – 50% OFF the regular price, use promo code "protein"
  • Broad coverage – Over 4,000 full-length human proteins
  • High Quality – Optimal preservation of protein structure and post-translational modifications
  • Limited Time – Expires on March 31st, 2018

 

 

(*) No additional/general discounts apply. Distributors should inquire conditions. The code "protein" is mandatory to receive the discount.

Posted in Promotions By Acris Antibodies

OriGene teamed up with Cell Press and created the CRISPR special edition book, a collection of CRISPR landmark articles and reviews in the recent year. You will find this beautiful book handy and informative.

Read More
Posted in Antibody News By Acris Antibodies

OriGene was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. For the past 20 years, we strived to become better and to prepare comprehensive, genome wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research.

OriGene could not have accomplished all this without the support of its customers. We also owe our growth and innovation to the success of our customers who continue their trust in our products. We would like to take this opportunity to say

"Thank You!"

for your continued support of OriGene Technologies.

To serve the European customers even better, OriGene has acquired Acris Antibodies to become the European Headquarter of OriGene. Acris Antibodies provides customer/technical service as well as the option to order any OriGene product locally in Europe.

Learn more about the special activities going on in the next weeks
and about OriGene´s milestones:

» Celebrating 20 Years with 20 Weeks of Fun and Giveaways «

Tags:

Posted in Antibody News By Acris Antibodies

Recent Studies Validate High performance and Accurate Results for UltraMAB®OTI1A4 as an Effective Screening Tool for ALK Translocation in Non-Small Cell Lung Cancer patients.

Rockville, MD – April 14, 2016. A pair of recently published studies shed light on the highly interesting area on detection of ALK expression among NSCLC patients by IHC. One study was conducted by NordiQC (Aalborg, Denmark), the other by a group of Germany scientists and was published in the Journal of Thoracic Oncology. Both studies compared the performance of OTI1A4 antibody from OriGene (Rockville, MD) and the D5F3 antibody from Ventana (Tucson, AZ) in a large set of lung cancer specimens with known ALK status identified by FISH assay.

Read More
Posted in Antibody News By Acris Antibodies

20 % Off All OriGene siRNAs

3/11/2016 1:35 AM

Read More
Posted in Promotions By Acris Antibodies
  • LinkedIn